A retrospective matched study associated Ze 185 prescribing with fewer benzodiazepine prescriptions, without proving that the herbal combination caused the difference.
What was compared
The study analyzed records from 3,252 psychiatric inpatients, including 1,548 with a prescription for the fixed herbal combination and 1,704 controls. Matching addressed several patient and admission characteristics. The Ze 185 group had fewer benzodiazepine prescriptions, while the authors described comparable clinical effectiveness of the treatment modalities.
Matching cannot remove every treatment-selection factor
Clinicians may have selected the herbal product for patients with different symptoms, preferences, severity, or expected benzodiazepine needs. A prescription count also differs from actual administration, cumulative dose, dependence, or withdrawal outcomes. The authors called for a dedicated randomized trial with safety monitoring. The study supplies a hypothesis about prescribing patterns, not evidence that the combination can reliably replace benzodiazepines or that every included botanical preparation has the same effects.
Source paper
Original analysis of the supplied journal article, identified as PMC7317844.
Leave a Reply